COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.
Latest Posts
-
-
Breaking newsCOVID-19ResearchA Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19 -
Breaking newsEAN NewsCOVID-19ResearchCOVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management
COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management -
Breaking newsCOVID-19ResearchA Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia
A Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia -
Breaking newsCOVID-19Research
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19 -
• Telemedicine consultations can aid effective epilepsy care, even for first visits. -
Caution is warranted with the use of antiseizure medications in the context of COVID-19 illness.
-
This neurology update focuses on mental well-being of people with epilepsy and their caregivers during the COVID-19 pandemic.
-
Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease.
-
This is an interesting work elucidating for the first time a role for ataxin-1 (ATXN1) mutation, traditionally linked to spinocerebellar ataxia-type 1 (SCA1), in the pathogenesis of Experimental Autoimmune Encephalomyelitis (EAE), the rodent model for Multiple Sclerosis (MS) -
The International Restless Legs Syndrome Study Group task force found sufficient evidence to formulate diagnostic criteria for pediatric clinical entity designated “restless sleep disorder”.
-
Societal Impact of Pain (SIP) is an international multi-stakeholder platform. Its long-term priorities are pain indicators, pain education, pain in employment, and pain research. This year traditional SIP Stakeholder Forum was on October 28th, 2020. -
Extra transparency measures for COVID-19 vaccines and therapeutics -
The European Brain Council (EBC) is very pleased to announce the launch of updated disease fact sheets, providing a quick overview of key facts, history, known causes, diagnosis, symptoms and treatment of brain disorders – neurological and mental alike. -
The European Medicines Agency (EMA) has a Healthcare Professionals’ Working Party (HCPWP) in which EAN participates since 2013. Meetings are mostly held together with the Consumers’ and Patients’ Working Party.